The Journal of Clinical Endocrinology & Metabolism · 1976 · 100 citations · 25 references
Life SciencesEndocrinologyPharmacologyEndocrine OncologyPharmacodynamicsSteroid BiochemistryAdrenal EndocrinologyAdrenal HormonesAdrenal Steroid HormonesHormonal TherapySteroid MetabolismSteroidogenesis RegulationAdrenal Androgen ProductionAdrenal Steroid Feedback RegulationAdrenal Steroidogenesis RegulationSteroid Responsiveness
Twelve cancer patients and one patient with diabetes mellitus were treated with medroxyprogesterone acetate (MPA) by intramuscular injection in a total weekly dose of 400, 700, or 1200 mg. The treatment reduced the plasma cortisol concentration by 76% in the AM hours (21 leads to 5.0 mug/dl) and by 75% in the PM hours (12.8 leads to 3.2 mug/dl). Cortisol production rate decreased by 67% (19 leads to 6.2 mg/24 hrs). The 24 hour profile of plasma cortisol concentration measured in 3 patients showed zero secretion over this period. Low plasma ACTH values prevailed during treatment, and a blunted response to maximal ACTH stimulation was found. No evidence of adrenal insufficiency was observed in any patient, even though in some patients the plasma cortisol concentration remained at zero for many weeks. MPA has cortisol-like effects and the suppression of adrenal function is probably mediated by a negative feedback action on the hypothalamus or pituitary.
25
Cortisol Is Secreted Episodically by Normal Man
LEON HELLMAN, Fujinori Nakada, Joseph Curti et al. · The Journal of Clinical Endocrinology & Metabolism · 1970 · 396 citations
ACTH and Cortisol Secretory Patterns in Man
T. F. Gallagher, Koichiro Yoshida, HOWARD D. ROFFWARG et al. · The Journal of Clinical Endocrinology & Metabolism · 1973 · 269 citations
Treatment of Breast Cancer with Medroxyprogesterone Acetate
Franco M. Muggia · Annals of Internal Medicine · 1968 · 78 citations
Medicine, Oncology, Pharmacology +17